Most frequently identified (>85% cases) is CIN, which presents as tumor genetic signature aberrations in oncogenes and/or tumor suppressor genes involved in key signaling pathways for cancer initiation and progression such as APC, KRAS, NRAS, PIK3CA, BRAF, and TP53 (17–20). The gene discussed is BRAF; the disease is neoplasm.